New paradigms for the use of prebiotics, probiotics, and synbiotics in renal disease

Katherine E. Twombley, Mouin G. Seikaly

Research output: Contribution to journalReview article


Prebiotics, probiotics, and synbiotics are now used more commonly in medicine, and they are generally considered to be dietary supplements and not drugs. They are not meant to be used for the treatment of disease, although recent interest has grown in the area of disease treatment. Not all of the research is in support of the benefit provided by these supplements, and it is important to be aware of the associated risks and benefi ts. In nephrology, these supplements show potential benefi ts in treating kidney stones, uremia, and urinary tract infections. This paper reviews the current literature with an emphasis on the risks and benefi ts of these supplements in the treatment of these renal disorders.

Original languageEnglish (US)
Pages (from-to)200-204
Number of pages5
JournalDialysis and Transplantation
Issue number5
StatePublished - May 1 2011


ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this